RIL
TAK icon

Rothschild Investment LLC’s Takeda Pharmaceutical TAK Stock Holding History

Rothschild Investment LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
19,966
+2,750
+16% +$45.5K 0.01% 742
2026
Q1 		$319K Buy
17,216
+734
+4% +$12.9K 0.02% 533
2025
Q4 		$257K Sell
16,482
-1,490
-8% -$21.3K 0.01% 540
2025
Q3 		$263K Sell
17,972
-1,323
-7% -$19.6K 0.01% 520
2025
Q2 		$298K Sell
19,295
-103
-0.5% -$1.52K 0.02% 427
2025
Q1 		$288K Buy
19,398
+578
+3% +$8.1K 0.02% 423
2024
Q4 		$249K Sell
18,820
-316
-2% -$4.34K 0.02% 455
2024
Q3 		$272K Sell
19,136
-5,500
-22% -$78K 0.02% 443
2024
Q2 		$319K Buy
24,636
+959
+4% +$12.7K 0.02% 410
2024
Q1 		$329K Sell
23,677
-269
-1% -$3.91K 0.02% 389
2023
Q4 		$342K Sell
23,946
-4,980
-17% -$70.7K 0.03% 337
2023
Q3 		$447K Sell
28,926
-66
-0.2% -$1.02K 0.04% 315
2023
Q2 		$455K Buy
28,992
+93
+0.3% +$1.52K 0.04% 313
2023
Q1 		$476K Sell
28,899
-1,423
-5% -$22.7K 0.04% 303
2022
Q4 		$473K Sell
30,322
-297
-1% -$4.15K 0.04% 295
2022
Q3 		$397K Sell
30,619
-155
-0.5% -$2.15K 0.04% 312
2022
Q2 		$432K Sell
30,774
-145
-0.5% -$2.07K 0.04% 319
2022
Q1 		$443K Hold
30,919
– – 0.03% 344
2021
Q4 		$421K Sell
30,919
-1,258
-4% -$17.6K 0.03% 351
2021
Q3 		$527K Sell
32,177
-729
-2% -$12.2K 0.04% 301
2021
Q2 		$554K Sell
32,906
-1,504
-4% -$25.6K 0.04% 307
2021
Q1 		$628K Buy
34,410
+1,862
+6% +$33.5K 0.05% 277
2020
Q4 		$592K Sell
32,548
-356
-1% -$6.25K 0.06% 263
2020
Q3 		$587K Buy
32,904
+779
+2% +$14.2K 0.06% 243
2020
Q2 		$576K Sell
32,125
-745
-2% -$13.4K 0.07% 227
2020
Q1 		$499K Buy
32,870
+256
+0.8% +$4.64K 0.07% 244
2019
Q4 		$643K Hold
32,614
– – 0.06% 260
2019
Q3 		$561K Hold
32,614
– – 0.07% 239
2019
Q2 		$577K Sell
32,614
-1,006
-3% -$18.3K 0.07% 235
2019
Q1 		$685K Buy
+33,620
New +$677K 0.08% 215

Other funds holding TAK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Rothschild Investment LLC's TAK Position: Q2 2026 in Review

Rothschild Investment LLC increased its Takeda Pharmaceutical (TAK) stake by 16% in Q2 2026, buying an estimated $45.5K and bringing the position to 19,966 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #742.

Rothschild Investment LLC first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $685K in Q1 2019. 199 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Rothschild Investment LLC held 19,966 shares of Takeda Pharmaceutical worth $320K as of Q2 2026.
  • Rothschild Investment LLC bought 2,750 Takeda Pharmaceutical shares in Q2 2026, an estimated $45.5K.
  • Takeda Pharmaceutical made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #742 holding.
  • Rothschild Investment LLC first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • Rothschild Investment LLC's Takeda Pharmaceutical position peaked at $685K in Q1 2019.
  • 199 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.